Stay updated on Subcutaneous Lirentelimab in Atopic Dermatitis Clinical Trial

Sign up to get notified when there's something new on the Subcutaneous Lirentelimab in Atopic Dermatitis Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Subcutaneous Lirentelimab in Atopic Dermatitis Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    Revision updated from v3.0.1 to v3.0.2 and the Back to Top link was removed; no substantive changes to core content.
    Difference
    0.2%
    Check dated 2025-09-14T22:13:50.000Z thumbnail image
  2. Check
    11 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content or important information.
    Difference
    0.2%
    Check dated 2025-09-07T19:34:55.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Summary
    The web page has undergone significant updates, including the addition of a facility name and specific drug safety information, while removing previous location details and versioning information.
    Difference
    2%
    Check dated 2025-08-31T12:28:48.000Z thumbnail image
  4. Check
    26 days ago
    No Change Detected
  5. Check
    33 days ago
    Change Detected
    Summary
    The web page has been updated from version v2.16.11 to v2.16.12.
    Difference
    0.1%
    Check dated 2025-08-17T04:46:35.000Z thumbnail image
  6. Check
    40 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.10 to version 2.16.11.
    Difference
    0.1%
    Check dated 2025-08-10T00:38:16.000Z thumbnail image
  7. Check
    47 days ago
    Change Detected
    Summary
    The web page has been updated to version 2.16.10, and a service alert regarding planned maintenance has been removed.
    Difference
    1%
    Check dated 2025-08-02T19:32:30.000Z thumbnail image

Stay in the know with updates to Subcutaneous Lirentelimab in Atopic Dermatitis Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Subcutaneous Lirentelimab in Atopic Dermatitis Clinical Trial page.